ScholarIQanswers from OpenAlex

Radiation Dose Reduction during Uterine Fibroid Embolization Using an Optimized Imaging Platform

PaperCitations, authors & open-access status

Radiation Dose Reduction during Uterine Fibroid Embolization Using an Optimized Imaging Platform is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Radiation Dose Reduction during Uterine Fibroid Embolization Using an Optimized Imaging Platform have?

ScholarIQcitation count

Radiation Dose Reduction during Uterine Fibroid Embolization Using an Optimized Imaging Platform has 11 citations in the OpenAlex counts ScholarIQ stores.

When was Radiation Dose Reduction during Uterine Fibroid Embolization Using an Optimized Imaging Platform published?

ScholarIQyear

Radiation Dose Reduction during Uterine Fibroid Embolization Using an Optimized Imaging Platform has 2017 year in the ScholarIQ index.

What is the open-access status of Radiation Dose Reduction during Uterine Fibroid Embolization Using an Optimized Imaging Platform?

ScholarIQoa status

Radiation Dose Reduction during Uterine Fibroid Embolization Using an Optimized Imaging Platform has closed oa status in the ScholarIQ index.

What is the DOI of Radiation Dose Reduction during Uterine Fibroid Embolization Using an Optimized Imaging Platform?

ScholarIQdoi

The DOI for Radiation Dose Reduction during Uterine Fibroid Embolization Using an Optimized Imaging Platform is on the source record.

What is the PMID of Radiation Dose Reduction during Uterine Fibroid Embolization Using an Optimized Imaging Platform?

ScholarIQpmid

The PMID for Radiation Dose Reduction during Uterine Fibroid Embolization Using an Optimized Imaging Platform is on the source record.

What is the OpenAlex record for Radiation Dose Reduction during Uterine Fibroid Embolization Using an Optimized Imaging Platform?

ScholarIQopenalex

The OpenAlex for Radiation Dose Reduction during Uterine Fibroid Embolization Using an Optimized Imaging Platform is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial